
Sign up to save your podcasts
Or
David Liew interviews Dr Paul Kubler on the pros and cons of fast-tracked approvals for new drugs – does it save patients or put their safety at risk?
4.5
1313 ratings
David Liew interviews Dr Paul Kubler on the pros and cons of fast-tracked approvals for new drugs – does it save patients or put their safety at risk?
754 Listeners
131 Listeners
861 Listeners
538 Listeners
104 Listeners
20 Listeners
24 Listeners
313 Listeners
134 Listeners
47 Listeners
17 Listeners
243 Listeners
4 Listeners
67 Listeners
10 Listeners